Guardant Health, Inc. (GH) Stock Overview
Explore Guardant Health, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Guardant Health, Inc. (GH)
Key Financials
Key Financials
Market Cap
17.3B
P/E Ratio
-38.95
EPS (TTM)
$-3.40
ROE
1.84%
GH Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Guardant Health, Inc. (GH) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 63.12, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $132.91.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -38.95 and a market capitalization of 17.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.